Compare AKAN & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKAN | NUWE |
|---|---|---|
| Founded | 2021 | 1999 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | 3.2M |
| IPO Year | 2021 | 2012 |
| Metric | AKAN | NUWE |
|---|---|---|
| Price | $0.87 | $4.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 165.2K | ★ 1.4M |
| Earning Date | 09-30-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,270,000.00 |
| Revenue This Year | N/A | $19.32 |
| Revenue Next Year | N/A | $12.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.42 | $0.28 |
| 52 Week High | $78.90 | $222.30 |
| Indicator | AKAN | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 24.26 | 47.14 |
| Support Level | $0.80 | $3.85 |
| Resistance Level | $1.11 | $13.14 |
| Average True Range (ATR) | 0.13 | 0.77 |
| MACD | 0.08 | 0.49 |
| Stochastic Oscillator | 13.11 | 72.63 |
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company is a medical cannabis & hemp and wellness platform company seeking to help people lives through improved access to high-quality and affordable products. The Company is also in the business of leasing fiber optic networks and telecommunication towers, through its subsidiary. The company has four reportable segments: Infrastructure, Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Infrastructure segment, which relates to the leasing and/or rental of fiber optic networks and telecommunication towers at First Towers in Mexico.
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.